30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States

Silence Therapeutics plc (SLN)

Track

Stock chart
Ticker: SLN
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Craig Tooman
Chief Financial Officer
1 purchase — total 200,006 USD
Buy 16 Apr 2021
Value US$2,149,888.67 | Price 410.40 | Shares 77,013
Buy 16 Apr 2021
Value US$3,384,411.54 | Price 498.27 | Shares 11,645
Buy 16 Apr 2021
Value US$5,010.53 | Price 23.09 | Shares 217
Buy 16 Apr 2021
Value US$100,002.79 | Price 23.09 | Shares 4,331
Buy 16 Apr 2021
Value US$100,002.79 | Price 23.09 | Shares 4,331
Buy 1 Dec 2020
Value US$103,740.00 | Price 18.20 | Shares 5,700
Buy 30 Nov 2020
Value US$25,112.70 | Price 5.58 | Shares 4,500
Buy 14 Oct 2020
Value £4,992.50 | Price 3.97 | Shares 1,258
Buy 9 Oct 2020
Value £19,977.80 | Price 4.04 | Shares 4,945
Buy 9 Oct 2020
Value £5,000.00 | Price 4.00 | Shares 1,250
Buy 8 Oct 2020
Value £12,262.50 | Price 4.09 | Shares 3,000
Buy 8 Oct 2020
Value £39,976.00 | Price 4.10 | Shares 9,750
Buy 28 May 2020
Value £74,260.00 | Price 4.70 | Shares 15,800
Sale 11 May 2020
Value £359,778.16 | Price 4.04 | Shares 89,054
Buy 2 Oct 2019
Value £5,993.19 | Price 1.89 | Shares 3,171
Buy 2 Oct 2019
Value £19,300.00 | Price 1.93 | Shares 10,000
Buy 30 Sep 2019
Value £47,000.00 | Price 1.88 | Shares 25,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-04-19 2021-04-16 B Purchase Craig Tooman

Chief Financial Officer

Officer
77,013
410.40
US$2,149,889 		77,013 410.40 US$2,149,889
2021-04-19 2021-04-16 B Purchase Mark Rothera

Chief Executive Officer and Executive Director

Executive Director
11,645
498.27
US$3,384,412 		11,645 498.27 US$3,384,412
2021-04-19 2021-04-16 B Purchase Dave Lemus

Non-Executive Director

Executive Director
84,141
290.65
US$2,672,066 		84,141 290.65 US$2,672,066
2021-04-19 2021-04-16 B Purchase Michael Davidson

Non-Executive Director

Executive Director
4,331
23.09
US$100,003 		4,331 23.09 US$100,003
2021-04-19 2021-04-16 B Purchase Steven Romano

Non-Executive Director

Executive Director
4,331
23.09
US$100,003 		4,331 23.09 US$100,003
2020-12-03 2020-12-01 B Purchase Mark Rothera

Chief Executive Officer

Officer
5,700
18.20
US$103,740 		5,700 18.20 US$103,740
2020-12-03 2020-11-30 B Purchase Dr. Steven Romano

Non-Executive Director

Executive Director
4,500
5.58
US$25,113 		4,500 5.58 US$25,113
2020-10-16 2020-10-14 B Purchase Alistair Gray

Non-Executive Director

Executive Director
1,258
3.97
£4,992 		1,258 3.97 £4,992
2020-10-12 2020-10-09 B Purchase Dr. Giles Campion

Executive Director

Executive Director
4,945
4.04
£19,978 		4,945 4.04 £19,978
2020-10-12 2020-10-09 B Purchase David Lemus

Non-Executive Director

Executive Director
1,250
4.00
£5,000 		1,250 4.00 £5,000
2020-10-12 2020-10-08 B Purchase James Ede-Golightly

Non-Executive Director

Executive Director
3,000
4.09
£12,262 		3,000 4.09 £12,262
2020-10-12 2020-10-08 B Purchase Iain Ross

Chairman

Director
9,750
4.10
£39,976 		9,750 4.10 £39,976
2020-05-29 2020-05-28 B Purchase Iain Ross

Executive Chairman

Director
15,800
4.70
£74,260 		15,800 4.70 £74,260
2020-05-12 2020-05-11 S Sale Rob Quinn

Chief Financial Officer

Officer
89,054
4.04
£359,778 		89,054 4.04 £359,778
2019-10-03 2019-10-02 B Purchase Alistair Gray

Non-Executive Director

Executive Director
3,171
1.89
£5,993 		3,171 1.89 £5,993
2019-10-02 2019-10-02 B Purchase Dr. Steven Romano

Non-Executive Director

Executive Director
10,000
1.93
£19,300 		10,000 1.93 £19,300
2019-09-30 2019-09-30 B Purchase Iain Ross

Non-Executive Chair

Director
25,000
1.88
£47,000 		25,000 1.88 £47,000
Explore more

More insider trading research around Silence Therapeutics plc

More insider trades in United States
Insider trading in North America